In crisis or thinking about suicide? Call or text 988 - the Suicide & Crisis Lifeline, free and confidential, 24 hours a day.
A National Resource The Depression Guide

From our survey

Explaining esketamine to a wary family member

When the word ketamine makes faces go flat: start with the problem, explain what it is and is not in one breath, and hand it to a doctor.

Your daughter heard the word "ketamine" and her face went flat. Your brother laughed and said something about horse tranquilizers. Your mother asked whether it was even legal. If you have tried to raise this subject in your family, you already know that the first obstacle is not the treatment. It is the word.

This explainer is for parents and family members who want to understand esketamine well enough to explain it calmly to someone who is wary, and who want to do that without overselling.

Wary is the normal starting point

In June 2026 our survey quizzed 443 grown-ups spread over ten Midwest states about what their gut says on hearing "ketamine therapy for depression or PTSD." Roughly a third, 34 percent, picked cautious but open, the single most common reply. Hopeful or curious drew another 18 percent. Counted as one group, those open answers make up 51 percent. Respondents calling themselves skeptical came to 21 percent, those unaware of it entirely to 18 percent, and a firmly negative reaction to just 9 percent.

The takeaway for a family is simple. Wariness is what most people feel. Your relative is not being difficult. They are being normal, and a careful explanation respects that.

Start with the problem it is meant for

Esketamine is not a first treatment for depression. It is meant for a specific situation: adults who have already given at least two antidepressants a fair trial, at proper doses, without enough relief. That is called treatment-resistant depression. Esketamine carries a second approval, alongside other care, covering grown patients whose major depression comes with acute suicidal thinking or behavior.

Starting here helps. You are not suggesting something exotic out of the blue. You are pointing out that when the usual medicines have not worked, there are approved next steps.

That situation is not rare. Our survey found 72 percent reporting depression, anxiety, or PTSD that ordinary medication failed to help, whether in their own life, in someone near them, or both.

Explain what it is, in one breath

Here is a one-sentence version you can use: "It's an FDA-approved nasal spray, related to ketamine, that you take at a certified clinic while staff watch you, for depression that regular antidepressants haven't budged."

Each part of that sentence answers a common fear:

  • "FDA-approved" answers "is this legit?" The FDA approved esketamine, sold as Spravato, in 2019.
  • "Nasal spray" answers "is this an IV or a pill I'd take at home?"
  • "At a certified clinic while staff watch you" answers "what if something goes wrong?"
  • "For depression that antidepressants haven't budged" answers "why would I need this?"

Explain how it is different from what they have heard

The "horse tranquilizer" joke comes from ketamine's long history as an anesthetic in both human and veterinary medicine, and from its misuse as a street drug. Esketamine is a related but distinct molecule, approved for a specific use and handled under strict rules.

It also helps to separate esketamine from two other things your relative may have seen:

  • Ketamine infusion clinics give ketamine through an IV. Using it for depression is off-label, which means the agency never signed off on it for that job.
  • At-home ketamine is often prescribed by telehealth companies as tablets or lozenges, taken without anyone present. That route is off-label too, and federal regulators have cautioned the public about it.

Many wary people are specifically worried about the unsupervised version. Learning that the approved treatment is never taken home can make a real difference. If you want something to show them, Brain Recovery Centers keeps a plain overview of how Spravato treatment works.

Explain what a session looks like

At a certified center, a patient uses the spray under the eye of a health care worker. They remain for a minimum of two hours as staff check blood pressure and watch for side effects. Typical ones are sleepiness, dizziness, nausea, and a passing sense of feeling disconnected or dreamlike. Those effects typically fade within the observation window.

Driving is off the table after a session until the following day, once the person has slept. The schedule usually starts at twice a week for roughly a month, drops to once a week, and later settles at weekly or every two weeks.

Telling your relative about the side effects up front is not a risk to the conversation. It builds trust. People who feel they have been told the downsides are more likely to take the upsides seriously.

Explain what it is not

  • It is not a sure thing. Some people improve and others do not.
  • It does not suit every patient. Someone with certain blood vessel problems, some heart or brain conditions, or blood pressure that is not under control may be ruled out.
  • It is not a replacement for a clinician's judgment. Only a clinician who knows your relative's history can say whether it fits.

Hand the question to a doctor

The most useful thing you can do after explaining is to point toward a clinician. Nothing in our survey moved people like their own doctor: 74 percent said that doctor's advice would get them to try it, far ahead of the 18 percent who picked a friend or relative.

That 18 percent is not nothing. Family matters. But family often matters most by helping someone get to the appointment, not by making the decision for them. You might try, "Nothing has to be decided today. Could you bring it up with your doctor next time?"

If they say no

Accept it for now. An adult family member has the right to decline, and pushing tends to harden caution into refusal. Leave the door open: "Okay. If you ever want to talk about it, or want me to come with you to an appointment, I'm here."

If your relative has talked about not wanting to live, set the treatment debate aside. Counselors at 988, the Suicide and Crisis Lifeline, pick up calls and texts at all hours, and a worried relative gets the same patient hearing as the one who is hurting.

Methodology

The publisher of this page paid for the study, which ran on the Pollfish consumer panel and stopped taking answers on June 23, 2026. By then 443 people between 18 and 64 had finished it, drawn from Kansas, Ohio, Missouri, Minnesota, Iowa, Indiana, Nebraska, Wisconsin, Illinois, and Oklahoma. Pollfish's validated final export is the source of every figure here. Split out by group, the 129 parents and other kin of veterans and first responders in the sample leaned open at 55 percent.